Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02OLS
|
||||
Former ID |
DIB014577
|
||||
Drug Name |
PPAR delta agonists
|
||||
Synonyms |
PPAR delta agonists (dyslipidemia/diabetes/obesity/atherosclerosis); PPAR delta agonists (dyslipidemia/diabetes/obesity/atherosclerosis), Astrazeneca
|
||||
Indication | Atherosclerosis [ICD9: 414.0, 440; ICD10:I70] | Investigative | [552085] | ||
Company |
AstraZeneca plc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1c(ccc(c1Cl)NC(=O)[C@H](N1Cc2c(CCC1)ccc(c2)OCC(=O)O)CC<br />)Cl
|
||||
Target and Pathway | |||||
Target(s) | Peroxisomeproliferator activated receptor delta | Target Info | Agonist | [543890] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
PANTHER Pathway | Wnt signaling pathway | ||||
Pathway Interaction Database | Presenilin action in Notch and Wnt signaling | ||||
RXR and RAR heterodimerization with other nuclear receptor | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.